SA
Strategic Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-9,235
| Closed | -$217K | – | 203 |
|
2024
Q2 | $217K | Sell |
9,235
-1,798
| -16% | -$42.2K | 0.04% | 191 |
|
2024
Q1 | $317K | Hold |
11,033
| – | – | 0.06% | 169 |
|
2023
Q4 | $362K | Sell |
11,033
-319
| -3% | -$10.5K | 0.07% | 157 |
|
2023
Q3 | $316K | Sell |
11,352
-47
| -0.4% | -$1.31K | 0.06% | 160 |
|
2023
Q2 | $389K | Sell |
11,399
-87
| -0.8% | -$2.97K | 0.07% | 145 |
|
2023
Q1 | $345K | Sell |
11,486
-6,656
| -37% | -$200K | 0.07% | 154 |
|
2022
Q4 | $512K | Sell |
18,142
-127
| -0.7% | -$3.59K | 0.11% | 125 |
|
2022
Q3 | $600K | Sell |
18,269
-471
| -3% | -$15.5K | 0.13% | 120 |
|
2022
Q2 | $590K | Sell |
18,740
-1,373
| -7% | -$43.2K | 0.12% | 121 |
|
2022
Q1 | $923K | Sell |
20,113
-1,758
| -8% | -$80.7K | 0.16% | 107 |
|
2021
Q4 | $1.34M | Sell |
21,871
-16,193
| -43% | -$991K | 0.19% | 97 |
|
2021
Q3 | $2.84M | Buy |
38,064
+858
| +2% | +$64.1K | 0.61% | 32 |
|
2021
Q2 | $3.44M | Sell |
37,206
-20,794
| -36% | -$1.92M | 0.89% | 23 |
|
2021
Q1 | $5.15M | Buy |
58,000
+647
| +1% | +$57.4K | 1.49% | 17 |
|
2020
Q4 | $5.93M | Buy |
57,353
+24,936
| +77% | +$2.58M | 1.71% | 15 |
|
2020
Q3 | $2.18M | Buy |
32,417
+6,540
| +25% | +$440K | 0.73% | 32 |
|
2020
Q2 | $1.48M | Buy |
25,877
+14,057
| +119% | +$801K | 0.55% | 38 |
|
2020
Q1 | $385K | Buy |
11,820
+3,707
| +46% | +$121K | 0.17% | 101 |
|
2019
Q4 | $272K | Buy |
8,113
+807
| +11% | +$27.1K | 0.09% | 144 |
|
2019
Q3 | $216K | Buy |
+7,306
| New | +$216K | 0.08% | 158 |
|